CMS Open Payments · Program Year 2024
Episurf Medical, Inc.
Episurf Medical, Inc. reported $295,051.45 across General Payments, Research, and Ownership to 34 physicians and teaching hospitals across 61 transactions.
- $295.1K
- All-tracks total
- 61
- Transactions
- 34
- Recipients
- +$14.9K
- General Payments vs PY2023
Episurf Medical, Inc. reported $295,051.45 across all CMS Open Payments tracks (General + Research + Ownership) to 34 physicians and teaching hospitals in Program Year 2024 - ranking #893 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $15,144.15, averaging $8.7K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer episurf-medical-inc Episurf Medical, Inc.
$295.1K · #893/1,925 · 0.0% industry · PY2024
- TOT $295.1K
- RANK #893
- SHARE 0.0%
- TXN 61
- RCP 34
- CAT 4
- GEN $15.1K
- ΔGEN +$14.9K
- TOP1 70.1%
- PY 2024
Volume peers
Nearest volume peer: IlluminOss Medical, Inc. ($293.7K)
Episurf Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Episurf Medical, Inc.'s CMS-reported General Payments increased by $14.9K (+5684.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: EPISURF MEDICAL, INC.PY2024: Episurf Medical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $261.83
- PY2024
- $15,144.15
What the Data Shows for Episurf Medical, Inc.
Rank #893 of 1,925 companies in CMS Open Payments for 2024 belongs to Episurf Medical, Inc., which reported $295,051.45 across 61 transactions to 34 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $4.8K per transaction and $8.7K per recipient.
Of the 4 general-payment categories charted below, "Travel and Lodging" is the largest at $6.8K across 1 transactions, 45.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Episurf Medical, Inc. made 4 types of general payments. "Travel and Lodging" is the largest category at $6.8K, 45.0% of General Payments.
Episurf Medical, Inc. reports 4 general-payment categories - the top three are Travel and Lodging (45.0%), Food and Beverage (24.0%), and Compensation for Faculty or Speaker (Medical Education) (18.5%). The remaining 1 category make up 12.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Episurf Medical, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $6.8K | 1 | 45.0% |
| Food and Beverage | $3.6K | 27 | 24.0% |
| Compensation for Faculty or Speaker (Medical Education) | $2.8K | 1 | 18.5% |
| Consulting Fee | $1.9K | 5 | 12.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $12,401.55 (81.9%) of $15,144.15 in this company's General Payments records across 27 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Episurf Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Gary Levengood
$10,620.04 across 6 reported transactions
- 2
Sean Kelly
$1,200.00 across 3 reported transactions
- 3
Phillip Omohundro
$200.17 across 1 reported transactions
- 4
Paul Morton
$191.09 across 1 reported transactions
- 5
Mark Campbell
$190.25 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Episurf Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Episurf Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Episurf Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Verity Pharmaceuticals Inc.
Nexxt Spine LLC
Evoke Pharma, Inc.
Exo Imaging, Inc.
Intra-Sana Laboratories
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.